Physician profile
Joshlene Sandhu
NPI 1902841448
$5,212.84
in general payments reported to CMS, 2019-2025
23 companies · $1,081 in 2025
The $1,081 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $213 · 2021: $696 · 2022: $1,029 · 2023: $755 · 2024: $1,126 · 2025: $1,081.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,961.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,238.74 | 2022-2025 | Miebo, Xiidra, Infuse |
| Mallinckrodt Hospital Products INC. | $882.45 | 2020-2025 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $607.23 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $528.70 | 2021-2025 | Acuvue |
| Coopervision INC. | $412.97 | 2020-2025 | Myday Contact Lens, Misight Contact Lens |
| Amgen INC. | $290.96 | 2024 | Tepezza |
| Lumenis Be INC | $212.18 | 2022 | |
| Dompe US, INC. | $141.40 | 2023-2025 | Oxervate |
| Aerie Pharmaceuticals, INC. | $137.29 | 2020-2021 | |
| Maculogix, INC. | $128.22 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $124.08 | 2019-2024 | Cequa |
| Abbvie INC. | $83.36 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $75.77 | 2024-2025 | Xdemvy |
| Carl Zeiss Meditec, INC. | $68.07 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $61.61 | 2019-2025 | Lipiflow System Activator (Disposable) |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $40.08 | 2019-2021 | |
| Alcon Vision LLC | $40.00 | 2019-2025 | Eysuvis |
| Shire North American Group INC | $27.48 | 2019 | |
| Ani Pharmaceuticals, INC. | $25.96 | 2025 | Purified Cortrophin Gel |
| Biotissue Holdings INC. | $24.51 | 2024 | |
| Akorn, INC. | $23.81 | 2020 | |
| Visioneering Technologies, INC. | $21.48 | 2019 | |
| Thea Pharma INC. | $16.49 | 2025 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshlene Sandhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.